PISANÒ, CLARISSA ANNA
PISANÒ, CLARISSA ANNA
Dipartimento di Scienze biomediche e chirurgico specialistiche (attivo dal 01/10/2012 al 31/12/2022)
6-Hydroxydopamine lesion and levodopa treatment modify the effect of buspirone in the substantia nigra pars reticulata
2020 Vegas-Suarez, S.; Pisano, C. A.; Requejo, C.; Bengoetxea, H.; Lafuente, J. V.; Morari, M.; Miguelez, C.; Ugedo, L.
Anti-Parkinsonian and anti-dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonists
2018 Arcuri, Ludovico; Novello, Salvatore; Frassineti, Martina; Mercatelli, Daniela; Pisano', Clarissa Anna; Morella, Ilaria; Fasano, Stefania; Journigan, Blair V; Meyer, Michael E; Polgar, Willma E; Brambilla, Riccardo; Zaveri, Nurulain T; Morari, Michele
Discovery and Structure-Activity Relationships of Nociceptin Receptor Partial Agonists That Afford Symptom Ablation in Parkinson's Disease Models
2020 Kamakolanu, U. G.; Meyer, M. E.; Yasuda, D.; Polgar, W. E.; Marti, M.; Mercatelli, D.; Pisano, C. A.; Brugnoli, A.; Morari, M.; Zaveri, N. T.
Leucine-rich repeat kinase 2 (LRRK2) inhibitors differentially modulate glutamate release and Serine935 LRRK2 phosphorylation in striatal and cerebrocortical synaptosomes
2019 Mercatelli, D.; Bolognesi, P.; Frassineti, M.; Pisano, C. A.; Longo, F.; Shimshek, D. R.; Morari, M.
Molecular and imaging prodromal markers of dopamine neuron degeneration in animal models of Parkinson’s disease: pathophysiology and clinical perspectives
file con accesso da definire2019 Morari, M.; Mercatelli, D.; Brugnoli, A.; Celeghini, C.; Pisanò, Ca
NOP receptor ligands and Parkinson’s disease
2019 Mercatelli, D.; Pisano, C. A.; Novello, S.; Morari, M.
Regulator of G-Protein Signalling 4 (RGS4) negatively modulates nociceptin/orphanin FQ opioid receptor signalling: Implication for L-Dopa-induced dyskinesia
2023 Pisano, C. A.; Mercatelli, D.; Mazzocchi, M.; Brugnoli, A.; Morella, I.; Fasano, S.; Zaveri, N. T.; Brambilla, R.; O'Keeffe, G. W.; Neubig, R. R.; Morari, M.
Safinamide differentially modulates in vivo glutamate and GABA release in the rat hippocampus and basal ganglia
2018 Morari, Michele; Brugnoli, Alberto; Pisanò, Clarissa Anna; Novello, Salvatore; Caccia, Carla; Melloni, Elsa; Padoani, Gloria; Vailati, Silvia; Sardina, Marco
Safinamide inhibits in vivo glutamate release in a rat model of Parkinson's disease
2020 Pisano, C. A.; Brugnoli, A.; Novello, S.; Caccia, C.; Keywood, C.; Melloni, E.; Vailati, S.; Padoani, G.; Morari, M.
Safinamide Modulates Striatal Glutamatergic Signaling in a Rat Model of Levodopa-Induced Dyskinesia
2018 Gardoni, F; Morari, M; Kulisevsky, J; Brugnoli, Alberto; Novello, S; Pisanò, CLARISSA ANNA; Caccia, C; Mellone, M; Melloni, E; Padoani, G; Sosti, V; Vailati, S; Keywood, C
Striatal and nigral muscarinic type 1 and type 4 receptors modulate levodopa-induced dyskinesia and striato-nigral pathway activation in 6-hydroxydopamine hemilesioned rats
2020 Brugnoli, A.; Pisano, C. A.; Morari, M.
Therapeutic potential of RGS4 blockade in movement disorders
2020 Pisanò, CLARISSA ANNA
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 6-Hydroxydopamine lesion and levodopa treatment modify the effect of buspirone in the substantia nigra pars reticulata | 2020 | Vegas-Suarez, S.; Pisano, C. A.; Requejo, C.; Bengoetxea, H.; Lafuente, J. V.; Morari, M.; Miguel...ez, C.; Ugedo, L. | |
| Anti-Parkinsonian and anti-dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonists | 2018 | Arcuri, Ludovico; Novello, Salvatore; Frassineti, Martina; Mercatelli, Daniela; Pisano', Clarissa... Anna; Morella, Ilaria; Fasano, Stefania; Journigan, Blair V; Meyer, Michael E; Polgar, Willma E; Brambilla, Riccardo; Zaveri, Nurulain T; Morari, Michele | |
| Discovery and Structure-Activity Relationships of Nociceptin Receptor Partial Agonists That Afford Symptom Ablation in Parkinson's Disease Models | 2020 | Kamakolanu, U. G.; Meyer, M. E.; Yasuda, D.; Polgar, W. E.; Marti, M.; Mercatelli, D.; Pisano, C.... A.; Brugnoli, A.; Morari, M.; Zaveri, N. T. | |
| Leucine-rich repeat kinase 2 (LRRK2) inhibitors differentially modulate glutamate release and Serine935 LRRK2 phosphorylation in striatal and cerebrocortical synaptosomes | 2019 | Mercatelli, D.; Bolognesi, P.; Frassineti, M.; Pisano, C. A.; Longo, F.; Shimshek, D. R.; Morari, M. | |
| Molecular and imaging prodromal markers of dopamine neuron degeneration in animal models of Parkinson’s disease: pathophysiology and clinical perspectives | 2019 | Morari, M.; Mercatelli, D.; Brugnoli, A.; Celeghini, C.; Pisanò, Ca | file con accesso da definire |
| NOP receptor ligands and Parkinson’s disease | 2019 | Mercatelli, D.; Pisano, C. A.; Novello, S.; Morari, M. | |
| Regulator of G-Protein Signalling 4 (RGS4) negatively modulates nociceptin/orphanin FQ opioid receptor signalling: Implication for L-Dopa-induced dyskinesia | 2023 | Pisano, C. A.; Mercatelli, D.; Mazzocchi, M.; Brugnoli, A.; Morella, I.; Fasano, S.; Zaveri, N. T....; Brambilla, R.; O'Keeffe, G. W.; Neubig, R. R.; Morari, M. | |
| Safinamide differentially modulates in vivo glutamate and GABA release in the rat hippocampus and basal ganglia | 2018 | Morari, Michele; Brugnoli, Alberto; Pisanò, Clarissa Anna; Novello, Salvatore; Caccia, Carla; Mel...loni, Elsa; Padoani, Gloria; Vailati, Silvia; Sardina, Marco | |
| Safinamide inhibits in vivo glutamate release in a rat model of Parkinson's disease | 2020 | Pisano, C. A.; Brugnoli, A.; Novello, S.; Caccia, C.; Keywood, C.; Melloni, E.; Vailati, S.; Pado...ani, G.; Morari, M. | |
| Safinamide Modulates Striatal Glutamatergic Signaling in a Rat Model of Levodopa-Induced Dyskinesia | 2018 | Gardoni, F; Morari, M; Kulisevsky, J; Brugnoli, Alberto; Novello, S; Pisanò, CLARISSA ANNA; Cacci...a, C; Mellone, M; Melloni, E; Padoani, G; Sosti, V; Vailati, S; Keywood, C | |
| Striatal and nigral muscarinic type 1 and type 4 receptors modulate levodopa-induced dyskinesia and striato-nigral pathway activation in 6-hydroxydopamine hemilesioned rats | 2020 | Brugnoli, A.; Pisano, C. A.; Morari, M. | |
| Therapeutic potential of RGS4 blockade in movement disorders | 2020 | Pisanò, CLARISSA ANNA |